• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Covidien

Covidien

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. BroadcastMed Celebrates 20 Years of Quality Healthcare Broadcasting

    BroadcastMed Celebrates 20 Years of Quality Healthcare Broadcasting

  2. Research and Markets: Global Endoscopy Equipment Market Forecasts & Opportunities 2014-2018: Endoscopes, Visualization Systems & Application

    Research and Markets: Global Endoscopy Equipment Market Forecasts & Opportunities 2014-2018: Endoscopes, Visualization Systems & Application

  3. Covidien's Wide-Moat Device Business Positioned Well for Long-Term Growth

    R&D investments and a narrowed focus have widened the firm's competitive advantages.

  4. Covidien's Mallinckrodt Spin-Off Faces Challenging Environment

    Mallinckrodt's lack of scale and weak branded business keep it from earning a moat.

  5. No Surprises in Medtronic's Fiscal Third Quarter

    The firm is on track to meet our full-year estimates, and our $60 per share fair value estimate and wide moat rating are intact.

  6. Our Outlook for Health-Care Stocks

    Health-care stocks are on a tear as demand slowly returns.

  7. Ideas From the Wide Moat Focus Index

    Morningstar StockInvestor editor Matt Coffina discusses recent additions to the Wide Moat Focus Index.

  8. Our Ultimate Stock-Pickers' Top 10 Buys and Sells

    Our top managers remain cautious, focusing more on relative valuation and increasing their willingness to book gains in the face of a rising (but potentially overvalued) market.

  9. Our Outlook for Health-Care Stocks

    With two years of stellar returns behind us, our expectations for 2013 are more muted, but some opportunities persist.

1234
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.